GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (STU:1UB) » Definitions » Enterprise Value

Cognetivity Neurosciences (STU:1UB) Enterprise Value : €1.53 Mil (As of Jun. 25, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cognetivity Neurosciences Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Cognetivity Neurosciences's Enterprise Value is €1.53 Mil. Cognetivity Neurosciences's EBIT for the trailing twelve months (TTM) ended in Oct. 2023 was €-2.81 Mil. Therefore, Cognetivity Neurosciences's EV-to-EBIT ratio for today is -0.55.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Cognetivity Neurosciences's Enterprise Value is €1.53 Mil. Cognetivity Neurosciences's EBITDA for the trailing twelve months (TTM) ended in Oct. 2023 was €-2.79 Mil. Therefore, Cognetivity Neurosciences's EV-to-EBITDA ratio for today is -0.55.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Cognetivity Neurosciences's Enterprise Value is €1.53 Mil. Cognetivity Neurosciences's Revenue for the trailing twelve months (TTM) ended in Oct. 2023 was €0.07 Mil. Therefore, Cognetivity Neurosciences's EV-to-Revenue ratio for today is 22.56.


Cognetivity Neurosciences Enterprise Value Historical Data

The historical data trend for Cognetivity Neurosciences's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cognetivity Neurosciences Enterprise Value Chart

Cognetivity Neurosciences Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Enterprise Value
Get a 7-Day Free Trial 11.25 5.75 24.79 26.78 13.29

Cognetivity Neurosciences Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.46 13.29 18.87 9.38 8.15

Competitive Comparison of Cognetivity Neurosciences's Enterprise Value

For the Health Information Services subindustry, Cognetivity Neurosciences's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cognetivity Neurosciences's Enterprise Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cognetivity Neurosciences's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Cognetivity Neurosciences's Enterprise Value falls into.



Cognetivity Neurosciences Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Cognetivity Neurosciences's Enterprise Value for the fiscal year that ended in Jan. 2023 is calculated as

Cognetivity Neurosciences's Enterprise Value for the quarter that ended in Oct. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cognetivity Neurosciences  (STU:1UB) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Cognetivity Neurosciences's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1.534/-2.81
=-0.55

Cognetivity Neurosciences's current Enterprise Value is €1.53 Mil.
Cognetivity Neurosciences's EBIT for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.81 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Cognetivity Neurosciences's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=1.534/-2.791
=-0.55

Cognetivity Neurosciences's current Enterprise Value is €1.53 Mil.
Cognetivity Neurosciences's EBITDA for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.79 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Cognetivity Neurosciences's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1.534/0.068
=22.56

Cognetivity Neurosciences's current Enterprise Value is €1.53 Mil.
Cognetivity Neurosciences's Revenue for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cognetivity Neurosciences Enterprise Value Related Terms

Thank you for viewing the detailed overview of Cognetivity Neurosciences's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Cognetivity Neurosciences (STU:1UB) Business Description

Traded in Other Exchanges
Address
800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6
Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.

Cognetivity Neurosciences (STU:1UB) Headlines

No Headlines